Back Page - Pharmaceutical Executive

ADVERTISEMENT

Back Page
A pharma miscellany.

Back Page: Where are the Women?

April 1, 2007

Despite efforts to increase diversity, the stark reality is that today's leading pharmaceutical companies are still run by men.

Back Page: Let's Get Gutsy

March 1, 2007

We all know that pharma is facing hard times: cut-throat competition, regulatory constraints, patent expirations, rusty pipelines, rising generics, falling revenues—and, perhaps most important, a firestorm of consumer anger over drug prices and safety now being restoked by the new Democratic Congress. Nevertheless, industry persists in "staying the course"—sound familiar?—rather than charting a bold new strategy. Its two top priorities remain opposing government price controls and thwarting patent laws favorable to generics. These defensive tactics are hardly the hallmark of leadership.

Back Page: While You Were Working

August 1, 2006

Do you remember where you were when Mevacor was approved? OK, what was on the radio at the time?

Back Page: Soft Serve, Hard Lessons

July 1, 2006

At first glance, you might think Bob Miglani comes from a pharma family. He and both of his younger sisters began their careers as sales reps after college. But behind their success in big business lie formative experiences at the Dairy Queen stores owned by their uncle and parents, who are immigrants from India. Even today, Miglani, whose fulltime job is in Pfizer's public affairs department, spends some weekends serving cones at the family business. In his new book, Treat Your Customers: Thirty Lessons on Service and Sales That I Learned at My Family's Dairy Queen Store (Hyperion, 2006), Miglani, 36, shares the core values that work in small business and corporate America.

Back Page: The "Help is Here" Express

June 1, 2006

Patient assistance programs have been around for a quarter of a century. But many patients have failed to reap the benefits because of confusion over eligibility and the mechanics of joining. But all that has become much easier with the Partnership for Prescription Assistance (PPA), a one-stop-shop for industry-sponsored assistance programs.

Back Page: Risk Assessment

May 1, 2006

Genomic researchers are developing tools to determine whether the right patients are taking statins.

Access for Dual Eligibles

April 1, 2006

Dual eligibles have less access to top brands than they did before the launch of Part D

Backpage: Warning Letter

March 1, 2006

This letter concerns the FDA press release dated January 18, 2006, entitled "FDA Announces New Prescription Drug Information Format to Improve Patient Safety." The information contained is considered false and misleading, and lacking in fair balance.

Backpage: Taking Hold of the Wheel

February 1, 2006

FDA's cautious approach to allowing drug manufacturers to communicate the economic value of drugs is contributing to an already poorly informed healthcare industry, and may be curtailing access to useful drugs.

ADVERTISEMENT

Click here